VBI Vaccines(Rehovot) is Drug Discovery in United States that focus on VBI Vaccines Inc business. Founded in 1965. They cover business area such as VBI Vaccines Inc, next-generation vaccine, unmet need, infectious disease, immuno-oncology, Sci-B-Vac product, adult, child, newborn, its product, Virus-Like Particle, vaccine platform, envelop virus-like particle vaccine.
1965
( 59 years old in 2024 )
VBI Vaccines Inc
-
222 Third Street
Suite 2241
Cambridge, MA 02142
United States
Private
VBI Vaccines Incnext-generation vaccineunmet needinfectious diseaseimmuno-oncologySci-B-Vac productadultchildnewbornits productVirus-Like Particlevaccine platformenvelop virus-like particle vaccine
* We use standard office opening hours in near VBI Vaccines(Rehovot)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
VBI Vaccines(Rehovot) is Drug Discovery business from United States that founded in 1965 (59 years old in 2024), VBI Vaccines(Rehovot) business is focusing on VBI Vaccines Inc.
VBI Vaccines(Rehovot) headquarter office and corporate office address is located in 222 Third Street Suite 2241 Cambridge, MA 02142 United States.
VBI Vaccines(Rehovot) was founded in United States.
In 2024, VBI Vaccines(Rehovot) is currently focus on VBI Vaccines Inc sector.
Above is snippet of Google Trends for "VBI Vaccines Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with VBI Vaccines(Rehovot), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
